氨氯地平贝那普利片对急性心肌梗死合并高血压患者外周血内皮微粒以及IL-6、IL-17水平的影响

邓毅凡, 刘娟, 孙珣, 戴承晔, 徐笑挺, 何胜虎, 张晶

中国药学杂志 ›› 2022, Vol. 57 ›› Issue (18) : 1571-1574.

PDF(987 KB)
PDF(987 KB)
中国药学杂志 ›› 2022, Vol. 57 ›› Issue (18) : 1571-1574. DOI: 10.11669/cpj.2022.18.011
论著

氨氯地平贝那普利片对急性心肌梗死合并高血压患者外周血内皮微粒以及IL-6、IL-17水平的影响

  • 邓毅凡1, 刘娟1, 孙珣2, 戴承晔2, 徐笑挺2, 何胜虎1, 张晶1*
作者信息 +

Effects of Amlodipine-Benazepril Tablets on Peripheral Blood Endothelial Microparticles and IL-6 and IL-17 Levels in Patients with Acute Myocardial Infarction Complicated with Hypertension

  • DENG Yi-fan1, LIU Juan1, SUN Xun2, DAI Cheng-ye2, XU Xiao-ting2, HE Sheng-hu1, ZHANG Jing1*
Author information +
文章历史 +

摘要

目的 探讨氨氯地平贝那普利片对急性心肌梗死合并高血压患者外周血内皮微粒(endothelial microparticles,EMPs)以及白介素-6(interleukin-6,IL-6)、白介素-17(interleukin-17,IL-17)水平的影响。方法 选取我院急性心肌梗死合并高血压病患共计208人,随机分为研究组和对照组予以不同降压方案,其中对照组106例选用苯磺酸氨氯地平片自由联合其他种类降压药物,研究组102例选用氨氯地平贝那普利片治疗,检测两组患者治疗前后心室质量指数、IL-6、IL-17以及EMPs水平,并定期随访统计患者治疗期间主要心血管不良事件(MACE)发生率、药物不良反应以及服药依从性。结果 2组病患经过上述治疗后,外周血IL-6、IL-17以及EMPs水平均有所下降;与对照组相比,研究组病患治疗后IL-6、IL-17以及EMPs水平下降幅度更大(P<0.05),MACE发生率更低,服药依从性更好(P<0.05),不同治疗方案的药物不良反应相比无统计学差异(P>0.05)。结论 氨氯地平贝那普利片能够明显降低急性心肌梗死合并高血压患者IL-6、IL-17以及EMPs水平,改善患者预后,服药依从性更好,值得推荐于临床使用。

Abstract

OBJECTIVE To investigate the effects of amlodipine-benazepril tablets on peripheral blood endothelial microparticles(EMPs), IL-6 and IL-17 levels in patients with acute myocardial infarction complicated with hypertension.CONCLUSION Selecting hospital diagnosis for patients with acute myocardial infarction, hypertension, a total of 208 people, will be randomly divided into two groups, control group 106 cases taking benzene sulfonic acid amlodipine free joint other antihypertensive drugs, study group 102 patients were treated with amlodipine-benazepril tablets. We detected of the groups before and after treatment in patients with ventricular mass index, IL-6, IL-17 and EMPs level. The incidence of major adverse cardiovascular events(MACE), adverse drug reactions, and medication compliance during treatment were analyzed during regular follow-up.RESULTS The levels of Il-6, IL-17 and EMPs decreased in both groups after treatment. Compared with the control group, the levels of IL-6, IL-17 and EMPs in the study group decreased significantly after treatment(P<0.05), the incidence of MACE was lower, and medication compliance was better(P<0.05). There was no statistical difference in adverse drug reactions between 2 groups(P>0.05).CONCLUSION Amlodipine-benazepril tablets can significantly reduce the levels of IL-6, IL-17 and EMPs in patients with acute myocardial infarction complicated with hypertension, improve the prognosis of patients with better medication compliance, which is worth recommending for clinical use.

关键词

急性心肌梗死 / 高血压 / 内皮微粒 / 白介素-6 / 白介素-17 / 内皮微粒

Key words

acute myocardial infarction / high blood pressure / endothelial microparticle / IL-6 / IL-17 / EMPs

引用本文

导出引用
邓毅凡, 刘娟, 孙珣, 戴承晔, 徐笑挺, 何胜虎, 张晶. 氨氯地平贝那普利片对急性心肌梗死合并高血压患者外周血内皮微粒以及IL-6、IL-17水平的影响[J]. 中国药学杂志, 2022, 57(18): 1571-1574 https://doi.org/10.11669/cpj.2022.18.011
DENG Yi-fan, LIU Juan, SUN Xun, DAI Cheng-ye, XU Xiao-ting, HE Sheng-hu, ZHANG Jing. Effects of Amlodipine-Benazepril Tablets on Peripheral Blood Endothelial Microparticles and IL-6 and IL-17 Levels in Patients with Acute Myocardial Infarction Complicated with Hypertension[J]. Chinese Pharmaceutical Journal, 2022, 57(18): 1571-1574 https://doi.org/10.11669/cpj.2022.18.011
中图分类号: R969   

参考文献

[1] RASTOGI R, SHEEHAN MM, HU B, et al. Treatment and Outcomes of Inpatient Hypertension Among Adults With Noncardiac Admissions[J]. JAMA Intern Med, 2021, 181(3): 345-352.
[2] WANG J, LI L, MA N, et al. Clinical investigation of acute myocardial infarction according to age subsets[J]. Exp Ther Med, 2020, 20(5): 120-120.
[3] PAINI A, TAROZZI L, BERTACCHINI F, et al. Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies[J]. J Hypertens, 2021, 39(12):2514-2520.
[4] YAN P, FAN W. Clinical trial investigators. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial[J]. Clin Exp Hypertens, 2014, 36(4): 268-274.
[5] THYGESEN K, ALPERT JS, JAFFE AS, et al. Fourth Universal Definition of Myocardial Infarction (2018)[J]. J Am Coll Cardiol, 2018, 72(18): 2231-2264.
[6] WRITING GROUP OF 2018 CHINESE GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION, CHINESE HYPERTENSION LEAGUE, CHINESE SOCIETY OF CARDIOLOGY, et al. 2018 Chinese guidelines for the management of hypertension[J]. Chin J Cardiovasc Med(中国心血管杂志), 2019, 24(1): 24-56.
[7] LI C, LI S, ZHANG F, et al. Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE-/- mice[J]. Biochem Biophys Res Commun, 2018, 495(2): 1922-1929.
[8] YUAN Y, MAITUSONG M, MUYESAI N. Association of endothelial and red blood cell microparticles with acute myocardial infarction in Chinese: a retrospective study[J]. Ann Palliat Med, 2020, 9(4): 1564-1570.
[9] ZHUANG F, BAO H, SHI Q, et al. Endothelial microparticles induced by cyclic stretch activate Src and modulate cell apoptosis[J]. FASEB J, 2020, 34(10): 13586-13596.
[10] BOLURI A, KHAZAEI H, SARGOLZAEI N, et al. The comparison of IL-17 levels in patients with unstable angina before and after medical treatment[J]. Human Antibodies, 2022, 30(1): 25-29.
[11] YANG J, DING X F, HE H, et al. Action Mechanism of the Factors of IL-17, IL-6 and IL-10 in Acute Coronary Syndrome[J]. Genomics Appl Biol(基因组学与应用生物学), 2019, 38(9): 4329-4334.
[12] LI D X, CHEN W, JIANG Y L, et al. Antioxidant protein peroxiredoxin 6 suppresses the vascular inflammation, oxidative stress and endothelial dysfunction in angiotensin II-induced endotheliocyte[J]. Gen Physiol Biophys, 2020, 39(6): 545-555.
[13] PLATTEN M, YOUSSEF S, HUR E M, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity[J]. Proc Natl Acad Sci USA, 2009, 106(35): 14948-14953.
[14] XIN K, GONG J Y, LUO J Q. Advances on pharmacogenomics of diuretics-related adverse reactions[J]. Chin J Clin Pharmacol(中国临床药理学与治疗学), 2021, 26(2):204-212.
[15] BROOK R D, KACIROTI N, BAKRIS G, et al. Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension[J]. Am J Hypertens, 2021, 34(5): 531-539.

基金

江苏省卫生健康委科研课题资助(Z2018032);扬州市重点研发(社会发展)项目资助(YZ2020103);2021年江苏省研究生科研与实践创新项目资助(SJCX21-1647)
PDF(987 KB)

219

Accesses

0

Citation

Detail

段落导航
相关文章

/